Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease
- PMID: 14978141
- DOI: 10.4049/jimmunol.172.5.3328
Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease
Abstract
Interleukin-7 has been shown to enhance T cell reconstitution after allogeneic bone marrow transplantation, in part, by expansion of mature donor T cells, but whether IL-7 also exacerbates graft-vs-host disease (GVHD) remains unresolved. To address this issue, we examined the effect of IL-7 on GVHD induction using a well-defined murine GVHD model (B6-->B6AF1/J). Administration of IL-7 to nonirradiated B6AF1/J recipients of B6 T cells resulted in expansion of splenic donor CD4(+) and CD8(+) T cells and increased GVHD mortality. In contrast, administration of IL-7 on the same schedule failed to increase GVHD mortality in either sublethally or lethally irradiated animals that received graded doses of T cells designed to induce varying degrees of GVHD severity. Moreover, IL-7 failed to increase the number of alloreactive T cells when examined in a murine model (B6-->BALB.B) that allowed for direct quantitation of graft-vs-host-reactive T cells. The combination of irradiation and transplantation of alloreactive donor T cells resulted in significantly increased levels of endogenous splenic IL-7 mRNA when compared with nonirradiated transplanted animals, providing a potential explanation for why exogenous IL-7 did not increase GVHD severity in these mice. We conclude that host conditioning modulates the ability of exogenous IL-7 to exacerbate GVHD and that this occurs through induction of endogenous IL-7 production.
Similar articles
-
The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning.J Immunol. 2002 Nov 15;169(10):5581-9. doi: 10.4049/jimmunol.169.10.5581. J Immunol. 2002. PMID: 12421935
-
Importance of interleukin-7 in the development of experimental graft-versus-host disease.Biol Blood Marrow Transplant. 2008 Jan;14(1):16-27. doi: 10.1016/j.bbmt.2007.07.015. Epub 2007 Dec 3. Biol Blood Marrow Transplant. 2008. PMID: 18158957
-
Kinetics of in vivo elimination of suicide gene-expressing T cells affects engraftment, graft-versus-host disease, and graft-versus-leukemia after allogeneic bone marrow transplantation.J Immunol. 2004 Sep 15;173(6):3620-30. doi: 10.4049/jimmunol.173.6.3620. J Immunol. 2004. PMID: 15356106
-
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.
-
New strategies for preventing graft-versus-host disease.Curr Opin Immunol. 1999 Oct;11(5):509-15. doi: 10.1016/s0952-7915(99)00002-3. Curr Opin Immunol. 1999. PMID: 10508701 Review.
Cited by
-
The Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical Overview.Front Immunol. 2016 Aug 30;7:333. doi: 10.3389/fimmu.2016.00333. eCollection 2016. Front Immunol. 2016. PMID: 27625651 Free PMC article. Review.
-
Nonalloreactive T cells prevent donor lymphocyte infusion-induced graft-versus-host disease by controlling microbial stimuli.J Immunol. 2012 Dec 15;189(12):5572-81. doi: 10.4049/jimmunol.1200045. Epub 2012 Nov 7. J Immunol. 2012. PMID: 23136200 Free PMC article.
-
Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation.Blood. 2012 Dec 6;120(24):4882-91. doi: 10.1182/blood-2012-06-437236. Epub 2012 Sep 25. Blood. 2012. PMID: 23012326 Free PMC article. Clinical Trial.
-
Homeostatic expansion and repertoire regeneration of donor T cells during graft versus host disease is constrained by the host environment.Blood. 2007 Jun 15;109(12):5502-10. doi: 10.1182/blood-2006-12-061713. Epub 2007 Mar 8. Blood. 2007. PMID: 17347406 Free PMC article.
-
Murine models of graft versus host disease (GVHD): Focus on ocular GVHD.Ocul Surf. 2023 Oct;30:179-186. doi: 10.1016/j.jtos.2023.09.006. Epub 2023 Sep 22. Ocul Surf. 2023. PMID: 37742740 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials